Related Experiment Video
Updated: Jul 18, 2026

Assessment of Vascular Function in Patients With Chronic Kidney Disease
Published on: June 16, 2014
Role of pulse pressure on cardiovascular risk in chronic kidney disease patients
Gema Fernandez-Fresnedo1, Emilio Rodrigo, Angel Luis Martin de Francisco
1Nephrology Service, Universitary Hospital Marqués de Valdecilla, Avda de Valdecilla, 39008, Santander, Spain. nefffg@humv.es
Insights
Pulse pressure (PP) is a crucial predictor of cardiovascular disease (CVD) and mortality, particularly in older adults and patients with chronic kidney disease (CKD). Understanding PP
Area of Science:
- Cardiology
- Nephrology
- Public Health
Background:
- High blood pressure (BP) is strongly linked to cardiovascular disease (CVD).
- Systolic BP and pulse pressure (PP) are increasingly recognized as key mortality predictors, especially in older populations.
- Chronic kidney disease (CKD) significantly elevates CVD risk and mortality, with hypertension being a major comorbidity across all stages.
Purpose of the Study:
- To review the significance of pulse pressure (PP) in predicting cardiovascular risk within the CKD population.
- To highlight PP as a prognostic factor in hemodialysis and renal transplant patients.
- To emphasize the role of PP in cardiovascular complications associated with kidney disease.
Main Methods:
- Review of epidemiologic and prospective studies.
- Analysis of existing literature on BP, PP, CVD, and CKD.
- Synthesis of data concerning mortality and morbidity in CKD patients with varying BP parameters.
Main Results:
- Pulse pressure (PP) is an independent predictor of myocardial infarction, heart failure, and cardiovascular death.
- PP is a reliable prognostic factor for mortality and CVD in CKD patients, including those on hemodialysis and transplant recipients.
- Arterial stiffness, reflected by PP, increases with age and is a critical factor in cardiovascular risk.
Conclusions:
- Pulse pressure (PP) is a vital marker for cardiovascular risk assessment in patients with chronic kidney disease (CKD).
- Monitoring PP is essential for managing cardiovascular complications in CKD, including kidney transplant recipients.
- Further research into PP's role can improve risk stratification and patient outcomes in nephrology and cardiology.
Abstract:
Epidemiologic studies have emphasized the close relationship between high BP and cardiovascular disease (CVD). Recently published prospective studies have focus on systolic and pulse pressure (PP). Systolic BP seems to be a more important factor than diastolic BP on cardiovascular and all-cause mortality in older patients. PP reflects stiffness of the large arteries and increases with age. Increasingly, PP is recognized as an independent predictor of myocardial infarction, congestive heart failure, and cardiovascular death, even in hypertensive patients who undergo successful antihypertensive drug therapy, especially in older individuals. Chronic kidney disease (CKD) is a major public health problem. The progression of kidney disease and its associated cardiovascular complications are the major causes of morbidity and mortality. This holds true for all stages of kidney disease, including ESRD that requires renal replacement therapy. Most of the traditional CVD risk factors are highly prevalent in CKD, and several nontraditional factors also are associated with atherosclerosis in CKD. The burden of hypertension is present at all stages of CKD. Several studies have shown that PP is a reliable prognostic factor for mortality and CVD in patients who have CKD and are on hemodialysis and in renal transplant patients. The purpose of this review is to show the importance of PP on cardiovascular risk in patients with CKD, including kidney transplant recipients.
Related Concept Videos
Chronic Kidney Disease I: Introduction
Chronic Kidney Disease IV: Nursing Management
Chronic Kidney Disease III: Interprofessional Care
Hypertension and Regulation of Blood Pressure
Chronic Kidney Disease II: Clinical Manifestations
Blood Pressure
